Associations Between Resolvin D1 and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients with ST-Segment Elevation Myocardial Infarction

References

• Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2015;13(2):79–98. doi:10.1038/nrcardio.2015.164
   PubMed Web of Science ®Google Scholar
• Tabas I. Tabas I: macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10(1):36–46. doi:10.1038/nri2675
   PubMed Web of Science ®Google Scholar
• Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136(12):1155–1166. doi:10.1161/CIRCULATIONAHA.117.029870
   PubMed Web of Science ®Google Scholar
• Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. The J Clin Invest. 2018;128(7):2657–2669. doi:10.1172/JCI97943
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101. doi:10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Pirault J, Back M. Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease. Front Pharmacol. 2018;9:1273. doi:10.3389/fphar.2018.01273
   PubMed Web of Science ®Google Scholar
• Thul S, Labat C, Temmar M, Benetos A, Back M. Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: a novel biomarker of non-resolving vascular inflammation. Eu J Prev Cardiol. 2017;24(9):903–906. doi:10.1177/2047487317694464
   PubMed Web of Science ®Google Scholar
• Ozgul Ozdemir RB, Soysal Gunduz O, Ozdemir AT, Akgul O. Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis. Immunol Lett. 2020;227:34–40. doi:10.1016/j.imlet.2020.08.006
   PubMed Web of Science ®Google Scholar
• Lutfioglu M, Aydogdu A, Sakallioglu EE, Alacam H, Pamuk F. Gingival crevicular fluid interleukin-8 and lipoxin A4 levels of smokers and nonsmokers with different periodontal status: a cross-sectional study. J Periodontal Res. 2016;51(4):471–480. doi:10.1111/jre.12324
   PubMed Web of Science ®Google Scholar
• Wu SH, Yin PL, Zhang YM, Tao HX. Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Pediatr Pulmonol. 2010;45(4):333–340. doi:10.1002/ppul.21186
   PubMed Web of Science ®Google Scholar
• Fredman G, Hellmann J, Proto JD, et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat Commun. 2016;7:12859. doi:10.1038/ncomms12859
   PubMed Web of Science ®Google Scholar
• Mena HA, Spite M. Spite M: proresolving receptor tames inflammation in atherosclerosis. J Clin Invest. 2021;131(24). doi:10.1172/JCI155240
   PubMed Web of Science ®Google Scholar
• Lee HN, Surh YJ. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochem Pharmacol. 2013;86(6):759–769. doi:10.1016/j.bcp.2013.07.002
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012;59(12):1058–1072. doi:10.1016/j.jacc.2011.09.079
   PubMed Web of Science ®Google Scholar
• Fracassi F, Crea F, Sugiyama T, et al. Healed culprit plaques in patients with acute coronary syndromes. J Am Coll Cardiol. 2019;73(18):2253–2263. doi:10.1016/j.jacc.2018.10.093
   PubMed Web of Science ®Google Scholar
• Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62(19):1748–1758. doi:10.1016/j.jacc.2013.05.071
   PubMed Web of Science ®Google Scholar
• Karayiğit O, Nurkoç SG, Başyiğit F, Kızıltunç E. The role of serum resolvin D1 levels in determining the presence and prognosis of ST-segment elevation myocardial infarction. Med Prin Pract. 2022;31(6):548–554. doi:10.1159/000527064
   PubMed Web of Science ®Google Scholar
• Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012;120(15):e60–72. doi:10.1182/blood-2012-04-423525
   PubMed Web of Science ®Google Scholar
• Fredman G. Can inflammation-resolution provide clues to treat patients according to their plaque phenotype? Front Pharmacol. 2019;10:205. doi:10.3389/fphar.2019.00205
   PubMed Web of Science ®Google Scholar
• Tangeten C, Zouaoui Boudjeltia K, Delporte C, Van Antwerpen P, Korpak K. Unexpected Role of MPO-Oxidized LDLs in atherosclerosis: in between inflammation and its resolution. Antioxidants (Basel). 2022;11(5). doi:10.3390/antiox11050874
   PubMedGoogle Scholar
• Cai B, Thorp EB, Doran AC, et al. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest. 2017;127(2):564–568. doi:10.1172/JCI90520
   PubMed Web of Science ®Google Scholar
• Chiurchiu V, Leuti A, Saracini S, et al. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes. FASEB J. 2019;33(1):909–916. doi:10.1096/fj.201801017R
   PubMed Web of Science ®Google Scholar
• Chen R, Liu C, Zhou P, et al. Both Low and High Postprocedural hsCRP associate with increased risk of death in acute coronary syndrome patients treated by percutaneous coronary intervention. Media Inflamm. 2020;2020:9343475. doi:10.1155/2020/9343475
   PubMed Web of Science ®Google Scholar
• Adriaenssens T, Allard-Ratick MP, Thondapu V, et al. Optical coherence tomography of coronary plaque progression and destabilization: JACC Focus Seminar Part 3/3. J Am Coll Cardiol. 2021;78(12):1275–1287. doi:10.1016/j.jacc.2021.07.032
   PubMed Web of Science ®Google Scholar
• Usui E, Mintz GS, Lee T, et al. Prognostic impact of healed coronary plaque in non-culprit lesions assessed by optical coherence tomography. Atherosclerosis. 2020;309:1–7. doi:10.1016/j.atherosclerosis.2020.07.005
   PubMed Web of Science ®Google Scholar
• Eickmeier O, Seki H, Haworth O, et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol. 2013;6(2):256–266. doi:10.1038/mi.2012.66
   PubMed Web of Science ®Google Scholar
• Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J. 2016;30(8):2792–2801. doi:10.1096/fj.201500155R
   PubMed Web of Science ®Google Scholar
• Makino Y, Miyahara T, Nitta J, et al. proresolving lipid mediators resolvin D1 and Protectin D1 isomer attenuate neointimal hyperplasia in the rat carotid artery balloon injury model. J Surg Res. 2019;233:104–110. doi:10.1016/j.jss.2018.07.049
   PubMed Web of Science ®Google Scholar
• Tintut Y, Honda HM, Demer LL. Biomolecules Orchestrating Cardiovascular Calcification. Biomolecules. 2021;11(10):1482. doi:10.3390/biom11101482
   PubMed Web of Science ®Google Scholar
• Hsu JJ, Tintut Y, Demer LL. Regulation of cardiovascular calcification by lipids and lipoproteins. Curr Opin Lipidol. 2022;33(5):289–294. doi:10.1097/MOL.0000000000000844
   PubMed Web of Science ®Google Scholar
• Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J Biol Chem. 2011;286(14):12213–12220. doi:10.1074/jbc.M110.214619
   PubMed Web of Science ®Google Scholar